FOLD Shares Hit 52-Week High: Time to Buy, Sell or Hold the Stock?
Key Takeaways FOLD touched a 52-week high as shares rally 87.6% in six months, beating the industry, sector and S&P 500.Galafold is the key revenue driver, generating 77.5M in the first nine months of 2025, reflecting 61.5% y/y growth.Shares of Amicus Therapeutics (FOLD) touched a 52-week high of 10.88.Shares of Amicus have surged 87.6% in the past six months compared w ...